<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996720</url>
  </required_header>
  <id_info>
    <org_study_id>fdpicu-04</org_study_id>
    <nct_id>NCT03996720</nct_id>
  </id_info>
  <brief_title>Early Identification and Effective Management of Pediatric Sepsis</brief_title>
  <official_title>Integration of Metabolic and Inflammatory Mediator Profiles as a Potential Diagnostic Approach for Severe Sepsis in PICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients diagnosed as sepsis on PICU admission, early and accurate identification of&#xD;
      patients who will develop organ dysfunction (severe sepsis) is critical for effective&#xD;
      management and positive outcome. A multiple marker approach would improve clinical utility&#xD;
      compared with use of a single marker. The primary goal of this part of study is to define a&#xD;
      combination of multiple markers, derived from novel biomarkers (nCD-64, IL-27, sTREM, HLA-DR,&#xD;
      IL-10), metabolomics and routine clinical parameters, which could predict severe sepsis and&#xD;
      determine the severity of disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We intend to enroll pediatric sepsis patients at four PICUs and divide them into two groups&#xD;
      based on clinical outcomes: severe sepsis group (patients who progress into severe sepsis),&#xD;
      sepsis group (patients who do not progress in to severe sepsis). We intend to perform&#xD;
      predictive modeling using multivariable analyses of the novel biomarkers and derive a&#xD;
      biomarker panel and algorithm for early diagnosis of severe sepsis. The predictive value of&#xD;
      the biomarker panel for early identification of severe sepsis will be compared with&#xD;
      established indices, such as PRISM III and pSOFA score.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>28 Days</target_duration>
  <primary_outcome>
    <measure>Severe sepsis</measure>
    <time_frame>28 day</time_frame>
    <description>Sepsis plus one of the following: cardiovascular organ dysfunction OR acute respiratory distress syndrome OR two or more other organ dysfunctions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>28 day</time_frame>
    <description>death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>secondary infection</measure>
    <time_frame>28 day</time_frame>
    <description>infection acquired 48h after PICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay</measure>
    <time_frame>28 day</time_frame>
    <description>from PICU admission to discharge</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">175</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>severe sepsis</arm_group_label>
    <description>patients who diagnosed as sepsis upon PICU admission and develop organ dysfunction during PICU stay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sepsis</arm_group_label>
    <description>patients recover from sepsis without developing into organ dysfunction</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      2ml of whole blood collected in sterile tubes containing EDTA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with sepsis from four tertiary PICUs in Shanghai&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The presence of at least two of the following four criteria, one of which must be&#xD;
             abnormal temperature or leukocyte count:&#xD;
&#xD;
               -  Coreb temperature of &gt;38.5°C or &lt;36°C.&#xD;
&#xD;
               -  Tachycardia, defined as a mean heart rate &gt;2 SD above normal for age in the&#xD;
                  absence of external stimulus, chronic drugs, or painful stimuli; or otherwise&#xD;
                  unexplained persistent elevation over a 0.5- to 4-hr time period OR for children&#xD;
                  &lt;1 yr old: bradycardia, defined as a mean heart rate &lt;10th percentile for age in&#xD;
                  the absence of external vagal stimulus, β-blocker drugs, or congenital heart&#xD;
                  disease; or otherwise unexplained persistent depression over a 0.5-hr time&#xD;
                  period.&#xD;
&#xD;
               -  Mean respiratory rate &gt;2 SD above normal for age or mechanical ventilation for an&#xD;
                  acute process not related to underlying neuromuscular disease or the receipt of&#xD;
                  general anesthesia.&#xD;
&#xD;
               -  Leukocyte count elevated or depressed for age (not secondary to&#xD;
                  chemotherapy-induced leukopenia) or &gt;10% immature neutrophils&#xD;
&#xD;
          -  A suspected or proven (by positive culture, tissue stain, or polymerase chain reaction&#xD;
             test) infection caused by any pathogen OR a clinical syndrome associated with a high&#xD;
             probability of infection. Evidence of infection includes positive findings on clinical&#xD;
             exam, imaging, or laboratory tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients without informed consent&#xD;
&#xD;
          -  discharge within 48 hours&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Guoping Lu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Shanghai</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Children's Medical Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xinhua Hospital Affiliated to Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolomics</keyword>
  <keyword>biomarkers</keyword>
  <keyword>inflammatory mediator profile</keyword>
  <keyword>MODS</keyword>
  <keyword>predictive model</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

